Dignitana AB Announces Change of Publication Date for Third Quarter 2018 Interim Report
Dignitana AB announced today that the Third Quarter 2018 Interim Report will be published the 16th of November instead of the previously posted date of 27 November 2018.
Financial Calendar
16 November 2018 -- Q3 Interim Report through 30 September 2018
26 February 2019 -- 2018 Year End Report
Past Annual Reports and Interim Reports are available at www.dignitana.se
Company Contact
William Cronin, CEO, Dignitana AB bill.cronin@dignitana.com +1 469 917 5555
Mikael Wahlgren, Vice VD, Dignitana AB mikael.wahlgren@dignitana.com +46 709 33 72 20
About Dignitana AB (publ)
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank is Certified Adviser. Learn more at www.dignitana.se and www.dignicap.com.
DigniCap long-term study demonstrates safety and efficacy of scalp cooling to reduce chemo hair loss
Dignitana expands customer service coverage in Europe with oneservice partnership
Dignitana expands partnership with Celeritas to improve scalp cooling technology available in Mexico
Dignitana announces proposal for Local Coverage Determination of scalp cooling therapy
Dignitana enters Hong Kong market with leading distributor Science International Corporation
Dignitana newsletter highlights growth, media coverage and exemplary customer satisfaction
Innovative treatment for hair loss from chemotherapy to be presented at Stora Aktiedagen